Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.09B |
| 2 |
Apple
AAPL
|
+$871M |
| 3 |
Uber
UBER
|
+$867M |
| 4 |
NVIDIA
NVDA
|
+$687M |
| 5 |
Amazon
AMZN
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$540M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.83% |
| 2 | Financials | 12.77% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
USAP
3151
DELISTED
Universal Stainless & Alloy
USAP
| $1.77M | ﹤0.01% |
87,950
+3,988
| +5% | +$60.2K |
|
3152
Lifecore Biomedical
LFCR
$164M
| $1.77M | ﹤0.01% |
285,085
+9,175
| +3% | +$63.7K |
|
|
LYRA
3153
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $1.76M | ﹤0.01% |
6,729
+555
| +9% | +$100K |
|
3154
Design Therapeutics
DSGN
$817M
| $1.76M | ﹤0.01% |
662,744
+28,024
| +4% | +$64.2K |
|
|
SEVN
3155
Seven Hills Realty Trust
SEVN
$174M
| $1.76M | ﹤0.01% |
135,612
+13,909
| +11% | +$157K |
|
3156
Workhorse Group
WKHS
$37.5M
| $1.75M | ﹤0.01% |
1,622
+207
| +15% | +$248K |
|
3157
HireQuest
HQI
$192M
| $1.75M | ﹤0.01% |
114,025
+2,572
| +2% | +$39.3K |
|
3158
Smith-Midland
SMID
$148M
| $1.75M | ﹤0.01% |
44,269
+3,986
| +10% | +$107K |
|
3159
Taysha Gene Therapies
TSHA
$1.75B
| $1.74M | ﹤0.01% |
985,421
+523,755
| +113% | +$1.04M |
|
3160
Consumer Portfolio Services
CPSS
$199M
| $1.74M | ﹤0.01% |
185,928
-483
| -0.3% | -$4.51K |
|
|
SGMO
3161
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.74M | ﹤0.01% |
3,206,310
+208,384
| +7% | +$96.1K |
|
3162
MarketWise
MKTW
$58.6M
| $1.73M | ﹤0.01% |
31,668
+2,833
| +10% | +$139K |
|
3163
Geospace Technologies
GEOS
$95.3M
| $1.73M | ﹤0.01% |
133,399
+8,795
| +7% | +$108K |
|
|
HARP
3164
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.7M | ﹤0.01% |
149,262
+124,349
| +499% | +$977K |
|
3165
Ocugen
OCGN
$434M
| $1.69M | ﹤0.01% |
2,929,948
+68,485
| +2% | +$27.4K |
|
3166
BigBear.ai
BBAI
$1.51B
| $1.68M | ﹤0.01% |
787,037
+48,821
| +7% | +$79K |
|
|
SACH
3167
Sachem Capital Corp
SACH
$41.2M
| $1.68M | ﹤0.01% |
449,505
+49,173
| +12% | +$176K |
|
3168
Cartesian Therapeutics
RNAC
$241M
| $1.68M | ﹤0.01% |
81,272
+1,780
| +2% | +$53.1K |
|
|
LNKB
3169
DELISTED
LINKBANCORP
LNKB
| $1.67M | ﹤0.01% |
210,004
+109,466
| +109% | +$723K |
|
3170
Energy Transfer Partners
ET
$70.8B
| $1.66M | ﹤0.01% |
120,086
+9,178
| +8% | +$125K |
|
|
THRX
3171
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $1.65M | ﹤0.01% |
407,822
+2,244
| +0.6% | +$6.85K |
|
3172
Indivior Pharmaceuticals
INDV
$4.33B
| $1.65M | ﹤0.01% |
108,032
+1,137
| +1% | +$20.2K |
|
|
GOEV
3173
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $1.64M | ﹤0.01% |
13,844
+3,666
| +36% | +$496K |
|
3174
Kornit Digital
KRNT
$791M
| $1.64M | ﹤0.01% |
85,464
+2,175
| +3% | +$37.7K |
|
|
CALB
3175
DELISTED
California BanCorp Common Stock
CALB
| $1.63M | ﹤0.01% |
65,719
+3,799
| +6% | +$84.3K |
|
Similar funds
Geode Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Geode Capital Management held 4,831 positions worth $956B, up 14% from $840B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q4 2023 filing shows 71 new, 3,576 increased, 304 reduced and 178 closed positions. Its largest new stake was NCR Atleos: 993,462 shares worth $24.2M. The largest sale was Activision Blizzard, an estimated $1.52B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2023 buy was NCR Atleos: 993,462 shares worth $24.2M.
- Geode Capital Management added most to Microsoft in Q4 2023, an estimated $1.09B increase.
- Geode Capital Management's biggest Q4 2023 reduction was Danaher, cutting an estimated $540M.
- Geode Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.52B.
- Geode Capital Management's ten largest holdings make up 26% of its $956B portfolio in Q4 2023.
- Geode Capital Management opened 71 new positions and closed 178 in Q4 2023.
- Geode Capital Management's portfolio value rose 14% quarter-over-quarter to $956B.
Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.